Tobramycin (0.3% w/v) is an ophthalmic solution belonging to the aminoglycoside class of antibiotics, widely used for the treatment of bacterial infections affecting the eye. Its primary mechanism of action involves binding to bacterial ribosomes and inhibiting protein synthesis, which effectively halts the growth and replication of susceptible microorganisms. This makes it particularly effective against Gram‑negative bacteria, while also providing coverage against certain Gram‑positive strains. Clinically, Tobramycin eye drops are employed in managing conditions such as conjunctivitis, keratitis, and blepharitis, where rapid antimicrobial action is essential to restore ocular health and prevent complications. The topical formulation ensures direct delivery to the site of infection, maximizing therapeutic efficacy while minimizing systemic exposure. In ophthalmic practice, Tobramycin is valued for its reliability, broad antibacterial spectrum, and ability to provide relief from discomfort associated with ocular infections. It is also frequently used in post‑operative care to reduce the risk of infection following eye surgeries. Overall, Tobramycin 0.3% w/v stands as a trusted and effective ophthalmic preparation, offering targeted antimicrobial protection, supporting healing, and safeguarding vision by maintaining a healthy ocular environment.